#1 Ranked Children’s Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
Large cell lymphoma is a type of non-Hodgkin lymphoma. It’s a cancer in the lymphatic system, which is part of the immune system, which works to fight disease and infections. Large cell lymphoma may develop in the lymph system tissue in the neck, chest, throat or abdomen.
How Dana-Farber/Boston Children’s approaches large cell lymphoma
Patients with large cell lymphoma are treated through Dana-Farber/Boston Children's Cancer and Blood Disorders Center, an integrated pediatric hematology and oncology partnership between Dana-Farber Cancer Institute and Boston Children’s Hospital. Specialists from Boston Children’s Hospital work very closely with the experts at Dana-Farber Cancer Institute to ensure that every aspect of your child’s health is overseen before, during and after his treatment period. Members of Lymphoma Program —specialists in oncology, radiation oncology, surgery, interventional and diagnostic radiology and hematopathology—have specialized expertise in pediatric lymphomas.
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”